Viscosupplementation Market By Type (Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation), By Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global viscosupplementation market was valued at $4,426.4 million in 2021, and is projected to reach $10,914.4 million by 2031, registering a CAGR of 9.5% from 2022 to 2031. Viscosupplementation, is a safe, non-surgical treatment for osteoarthritis. It is Food and Drug Administration (FDA)-approved and more successful for the treatment of patients with early-stage arthritis. During viscosupplementation, a gel-like material (hyaluronic acid) is pushed into the kneecap. The naturally occurring chemical hyaluronic acid is found in the synovial fluid that surrounds joints. It lubricates joints to allow bones to move freely and lessen discomfort. Hyaluronic acid levels in the joints are lower in those with osteoarthritis, which causes pain. The injected gel, which is produced in biological research facilities, functions as a cushion and lubricates the joints. Hyaluronic acid forms protein-protein bonds with a variety of proteins, making ligaments more resilient under strain.
The viscosupplementation market is driven by rise in the prevalence of osteoarthritis, increasing geriatric population and rise in adoption of minimally invasive surgeries. Geriatric population is more susceptible to osteoarthritis, therefore rise in the geriatric population anticipated to fuel the demand of viscosupplementation. Thus, this factor is attributes to drive the growth of viscosupplementation market. For instance, according to the World Health Organization (WHO) in October 2021, by 2030, 1 in 6 population in the world will be aged 60 years or over. In addition, rise in the prevalence of osteoarthritis anticipated to fuel the demand of viscosupplementation, henceforth anticipated to boost the growth of viscosupplementation market. For instance, according to Centers for Disease Control, (CDC), it was reported that, by 2040, an estimated 78 million (26%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis. In addition, rise in the demand for minimally invasive viscosupplementation procedures for treatment of osteoarthritis will enhance the industry growth. The minimally invasive treatment replaces synovial fluid by intra-articular injection of hyaluronic acid. As the cost of minimally invasive procedures is significantly less than the conventional procedures, the market will witness considerable growth during the forecast period.
In addition, governments globally have increased the expenditure on the healthcare sector. For instance, according to the Centers for Medicare & Medicaid Services, the U.S. health care spending grew by 9.7% from 2019 to 2020 reaching $4.1 trillion ($12,530 per person). Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it has been estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment, medicine and material used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for viscosupplementation application in osteoarthritis treatment, thereby boosting the market growth.
On the other hand, high cost of hyaluronic acid and presence of alternative for knee osteoarthritis treatment are some factors that are anticipated to restrain the growth of the viscosupplementation market.
The viscosupplementation market is segmented on the basis of product, application, distribution channel, and region. On the basis of product, the market is segmented into single injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation. On the basis of application, the market is bifurcated into knee osteoarthritis, hip osteoarthritis, hand osteoarthritis and others. On the basis of knee osteoarthritis market is divided into gender. On the basis of distribution channel, the market is classified into hospital pharmacies, retail pharmacies and online pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global viscosupplementation market include Seikagaku Corporation, Anika Therapeutics, Inc. APTISSEN, Avanos Medical, Inc., Bioventus, Chugai Pharmaceutical Corp., Fidia Farmaceutici S.P.A, Laboratoires VIVACY, LG Life Sciences Ltd., Miravo Healthcare, Neopharmed Gentili S.p.A., Sanofi, SingHealth Group., Smith & Nephew PLC, Viatris, Zimmer Biomet.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the viscosupplementation market analysis from 2021 to 2031 to identify the prevailing viscosupplementation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the viscosupplementation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global viscosupplementation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Single Injection Viscosupplementation
Three Injection Viscosupplementation
Five Injection Viscosupplementation
By Application
Others
Knee Osteoarthritis
Gender
Male
Female
Hip Osteoarthritis
Hand Osteoarthritis
By Distribution channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
Seikagaku Corporation
Anika Therapeutics, Inc.
aptissen
Avanos Medical, Inc.
Bioventus
Chugai Pharmaceutical Corp.
Fidia Farmaceutici S.P.A
LG Life Sciences Ltd.
Sanofi
Miravo Healthcare
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: VISCOSUPPLEMENTATION MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Single Injection Viscosupplementation
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Three Injection Viscosupplementation
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Five Injection Viscosupplementation
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: VISCOSUPPLEMENTATION MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Knee Osteoarthritis
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Knee Osteoarthritis Viscosupplementation Market by Gender
- 5.2.4.1 Male Market size and forecast, by region
- 5.2.4.2 Female Market size and forecast, by region
- 5.3 Hip Osteoarthritis
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Hand Osteoarthritis
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospital Pharmacies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Retail Pharmacies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Online Pharmacies
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: VISCOSUPPLEMENTATION MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.3.1 North America Knee Osteoarthritis Viscosupplementation Market by Gender
- 7.2.4 North America Market size and forecast, by Distribution channel
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by Distribution channel
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by Distribution channel
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by Distribution channel
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.3.1 Europe Knee Osteoarthritis Viscosupplementation Market by Gender
- 7.3.4 Europe Market size and forecast, by Distribution channel
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by Distribution channel
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by Distribution channel
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by Distribution channel
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by Distribution channel
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by Distribution channel
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Type
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by Distribution channel
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.3.1 Asia-Pacific Knee Osteoarthritis Viscosupplementation Market by Gender
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution channel
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by Distribution channel
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by Distribution channel
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by Distribution channel
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by Distribution channel
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by Distribution channel
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Type
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by Distribution channel
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.3.1 LAMEA Knee Osteoarthritis Viscosupplementation Market by Gender
- 7.5.4 LAMEA Market size and forecast, by Distribution channel
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by Distribution channel
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by Distribution channel
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by Distribution channel
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Type
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by Distribution channel
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Seikagaku Corporation
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Anika Therapeutics, Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 aptissen
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Avanos Medical, Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Bioventus
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Chugai Pharmaceutical Corp.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Fidia Farmaceutici S.P.A
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 LG Life Sciences Ltd.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Sanofi
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Miravo Healthcare
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 2. VISCOSUPPLEMENTATION MARKET, FOR SINGLE INJECTION VISCOSUPPLEMENTATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. VISCOSUPPLEMENTATION MARKET FOR SINGLE INJECTION VISCOSUPPLEMENTATION, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. VISCOSUPPLEMENTATION MARKET, FOR THREE INJECTION VISCOSUPPLEMENTATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 5. VISCOSUPPLEMENTATION MARKET FOR THREE INJECTION VISCOSUPPLEMENTATION, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 6. VISCOSUPPLEMENTATION MARKET, FOR FIVE INJECTION VISCOSUPPLEMENTATION, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. VISCOSUPPLEMENTATION MARKET FOR FIVE INJECTION VISCOSUPPLEMENTATION, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 9. VISCOSUPPLEMENTATION MARKET, FOR KNEE OSTEOARTHRITIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. VISCOSUPPLEMENTATION MARKET FOR KNEE OSTEOARTHRITIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 11. GLOBAL KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET, BY GENDER, 2021-2031 ($MILLION)
- TABLE 12. VISCOSUPPLEMENTATION MARKET, FOR MALE, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. VISCOSUPPLEMENTATION MARKET, FOR FEMALE, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. VISCOSUPPLEMENTATION MARKET, FOR HIP OSTEOARTHRITIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. VISCOSUPPLEMENTATION MARKET FOR HIP OSTEOARTHRITIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. VISCOSUPPLEMENTATION MARKET, FOR HAND OSTEOARTHRITIS, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. VISCOSUPPLEMENTATION MARKET FOR HAND OSTEOARTHRITIS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. VISCOSUPPLEMENTATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. VISCOSUPPLEMENTATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 21. VISCOSUPPLEMENTATION MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. VISCOSUPPLEMENTATION MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. VISCOSUPPLEMENTATION MARKET, FOR RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. VISCOSUPPLEMENTATION MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. VISCOSUPPLEMENTATION MARKET, FOR ONLINE PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. VISCOSUPPLEMENTATION MARKET FOR ONLINE PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 27. VISCOSUPPLEMENTATION MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 28. NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 29. NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 30. NORTH AMERICA KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET, BY GENDER, 2021-2031 ($MILLION)
- TABLE 31. NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 32. NORTH AMERICA VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 33. U.S. VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 34. U.S. VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 35. U.S. VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 36. CANADA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 37. CANADA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 38. CANADA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 39. MEXICO VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 40. MEXICO VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 41. MEXICO VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 42. EUROPE VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 43. EUROPE VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. EUROPE KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET, BY GENDER, 2021-2031 ($MILLION)
- TABLE 45. EUROPE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 46. EUROPE VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 47. GERMANY VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. GERMANY VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 49. GERMANY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 50. FRANCE VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. FRANCE VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 52. FRANCE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 53. UK VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 54. UK VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 55. UK VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 56. ITALY VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 57. ITALY VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 58. ITALY VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 59. SPAIN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 60. SPAIN VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 61. SPAIN VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 62. REST OF EUROPE VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 63. REST OF EUROPE VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 64. REST OF EUROPE VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 65. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 66. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 67. ASIA-PACIFIC KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET, BY GENDER, 2021-2031 ($MILLION)
- TABLE 68. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 69. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 70. CHINA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 71. CHINA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 72. CHINA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 73. JAPAN VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 74. JAPAN VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 75. JAPAN VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 76. INDIA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 77. INDIA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. INDIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 79. AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 80. AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 81. AUSTRALIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 82. SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 83. SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. SOUTH KOREA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 85. REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 86. REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 87. REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 88. LAMEA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 89. LAMEA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 90. LAMEA KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET, BY GENDER, 2021-2031 ($MILLION)
- TABLE 91. LAMEA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 92. LAMEA VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 93. BRAZIL VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 94. BRAZIL VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 95. BRAZIL VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 96. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 97. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 98. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 99. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 100. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 101. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 102. REST OF LAMEA VISCOSUPPLEMENTATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 103. REST OF LAMEA VISCOSUPPLEMENTATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 104. REST OF LAMEA VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 105.SEIKAGAKU CORPORATION: COMPANY SNAPSHOT
- TABLE 106.SEIKAGAKU CORPORATION: OPERATING SEGMENTS
- TABLE 107.SEIKAGAKU CORPORATION: PRODUCT PORTFOLIO
- TABLE 108.SEIKAGAKU CORPORATION: NET SALES,
- TABLE 109.SEIKAGAKU CORPORATION: KEY STRATERGIES
- TABLE 110.ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT
- TABLE 111.ANIKA THERAPEUTICS, INC.: OPERATING SEGMENTS
- TABLE 112.ANIKA THERAPEUTICS, INC.: PRODUCT PORTFOLIO
- TABLE 113.ANIKA THERAPEUTICS, INC.: NET SALES,
- TABLE 114.ANIKA THERAPEUTICS, INC.: KEY STRATERGIES
- TABLE 115.APTISSEN: COMPANY SNAPSHOT
- TABLE 116.APTISSEN: OPERATING SEGMENTS
- TABLE 117.APTISSEN: PRODUCT PORTFOLIO
- TABLE 118.APTISSEN: NET SALES,
- TABLE 119.APTISSEN: KEY STRATERGIES
- TABLE 120.AVANOS MEDICAL, INC.: COMPANY SNAPSHOT
- TABLE 121.AVANOS MEDICAL, INC.: OPERATING SEGMENTS
- TABLE 122.AVANOS MEDICAL, INC.: PRODUCT PORTFOLIO
- TABLE 123.AVANOS MEDICAL, INC.: NET SALES,
- TABLE 124.AVANOS MEDICAL, INC.: KEY STRATERGIES
- TABLE 125.BIOVENTUS: COMPANY SNAPSHOT
- TABLE 126.BIOVENTUS: OPERATING SEGMENTS
- TABLE 127.BIOVENTUS: PRODUCT PORTFOLIO
- TABLE 128.BIOVENTUS: NET SALES,
- TABLE 129.BIOVENTUS: KEY STRATERGIES
- TABLE 130.CHUGAI PHARMACEUTICAL CORP.: COMPANY SNAPSHOT
- TABLE 131.CHUGAI PHARMACEUTICAL CORP.: OPERATING SEGMENTS
- TABLE 132.CHUGAI PHARMACEUTICAL CORP.: PRODUCT PORTFOLIO
- TABLE 133.CHUGAI PHARMACEUTICAL CORP.: NET SALES,
- TABLE 134.CHUGAI PHARMACEUTICAL CORP.: KEY STRATERGIES
- TABLE 135.FIDIA FARMACEUTICI S.P.A: COMPANY SNAPSHOT
- TABLE 136.FIDIA FARMACEUTICI S.P.A: OPERATING SEGMENTS
- TABLE 137.FIDIA FARMACEUTICI S.P.A: PRODUCT PORTFOLIO
- TABLE 138.FIDIA FARMACEUTICI S.P.A: NET SALES,
- TABLE 139.FIDIA FARMACEUTICI S.P.A: KEY STRATERGIES
- TABLE 140.LG LIFE SCIENCES LTD.: COMPANY SNAPSHOT
- TABLE 141.LG LIFE SCIENCES LTD.: OPERATING SEGMENTS
- TABLE 142.LG LIFE SCIENCES LTD.: PRODUCT PORTFOLIO
- TABLE 143.LG LIFE SCIENCES LTD.: NET SALES,
- TABLE 144.LG LIFE SCIENCES LTD.: KEY STRATERGIES
- TABLE 145.SANOFI: COMPANY SNAPSHOT
- TABLE 146.SANOFI: OPERATING SEGMENTS
- TABLE 147.SANOFI: PRODUCT PORTFOLIO
- TABLE 148.SANOFI: NET SALES,
- TABLE 149.SANOFI: KEY STRATERGIES
- TABLE 150.MIRAVO HEALTHCARE: COMPANY SNAPSHOT
- TABLE 151.MIRAVO HEALTHCARE: OPERATING SEGMENTS
- TABLE 152.MIRAVO HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 153.MIRAVO HEALTHCARE: NET SALES,
- TABLE 154.MIRAVO HEALTHCARE: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.VISCOSUPPLEMENTATION MARKET SEGMENTATION
- FIGURE 2.VISCOSUPPLEMENTATION MARKET,2021-2031
- FIGURE 3.VISCOSUPPLEMENTATION MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.VISCOSUPPLEMENTATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.VISCOSUPPLEMENTATION MARKET,BY TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SINGLE INJECTION VISCOSUPPLEMENTATION VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF THREE INJECTION VISCOSUPPLEMENTATION VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FIVE INJECTION VISCOSUPPLEMENTATION VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 16.VISCOSUPPLEMENTATION MARKET,BY APPLICATION,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF KNEE OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HIP OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HAND OSTEOARTHRITIS VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 21.VISCOSUPPLEMENTATION MARKET,BY DISTRIBUTION CHANNEL,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF RETAIL PHARMACIES VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PHARMACIES VISCOSUPPLEMENTATION MARKET,2021-2031(%)
- FIGURE 25.VISCOSUPPLEMENTATION MARKET BY REGION,2021
- FIGURE 26.U.S. VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 31.UK VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 35.CHINA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 37.INDIA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 38.AUSTRALIA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA VISCOSUPPLEMENTATION MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.SEIKAGAKU CORPORATION.: NET SALES ,($MILLION)
- FIGURE 52.ANIKA THERAPEUTICS, INC..: NET SALES ,($MILLION)
- FIGURE 53.APTISSEN.: NET SALES ,($MILLION)
- FIGURE 54.AVANOS MEDICAL, INC..: NET SALES ,($MILLION)
- FIGURE 55.BIOVENTUS.: NET SALES ,($MILLION)
- FIGURE 56.CHUGAI PHARMACEUTICAL CORP..: NET SALES ,($MILLION)
- FIGURE 57.FIDIA FARMACEUTICI S.P.A.: NET SALES ,($MILLION)
- FIGURE 58.LG LIFE SCIENCES LTD..: NET SALES ,($MILLION)
- FIGURE 59.SANOFI.: NET SALES ,($MILLION)
- FIGURE 60.MIRAVO HEALTHCARE.: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook